MacroGenics | MGNX - Чистый доход





Чистый доход Изменить Дата
AbbVie USD 695M 1.12B 2026-03
Amgen USD 1.82B 486M 2026-03
AstraZeneca USD 3.08B 754M 2026-03
Biogen USD 319.5M 368.4M 2026-03
Bristol-Myers Squibb USD 2.68B 1.59B 2026-03
Daiichi Sankyo JPY 86.63B 41.32B 2025-12
Eli Lilly USD 7.4B 760M 2026-03
Genmab DKK 31M 370M 2025-12
Geron USD -3.64M 27.5M 2026-03
Gilead Sciences USD 2.02B 162M 2026-03
J&J USD 5.24B 119M 2026-03
Karyopharm Therapeutics USD -102.2M 71.42M 2025-12
MacroGenics USD -36.77M 22.62M 2026-03
Merck USD -4.24B 7.2B 2026-03
Pfizer USD 2.69B 4.34B 2026-03
Puma Biotechnology USD 20.32M 24.85M 2024-09
Regeneron Pharmaceuticals USD 727.2M 117.4M 2026-03
Roche Holding CHF 5.47B 1.76B 2025-12
Xencor USD -128.92M 122.26M 2026-03